Development of PLGA-coated β-TCP scaffolds containing VEGF for bone tissue engineering.

Bone tissue engineering is sought to apply strategies for bone defects healing without limitations and short-comings of using either bone autografts or allografts and xenografts. The aim of this study was to fabricate a thin layer poly(lactic-co-glycolic) acid (PLGA) coated beta-tricalcium phosphate (β-TCP) scaffold with sustained release of vascular endothelial growth factor (VEGF). PLGA coating increased compressive strength of the β-TCP scaffolds significantly. For in vitro evaluations, canine mesenchymal stem cells (cMSCs) and canine endothelial progenitor cells (cEPCs) were isolated and characterized. Cell proliferation and attachment were demonstrated and the rate of cells proliferation on the VEGF released scaffold was significantly more than compared to the scaffolds with no VEGF loading. A significant increase in expression of COL1 and RUNX2 was indicated in the scaffolds loaded with VEGF and MSCs compared to the other groups. Consequently, PLGA coated β-TCP scaffold with sustained and localized release of VEGF showed favourable results for bone regeneration in vitro, and this scaffold has the potential to use as a drug delivery device in the future.

[1]  H. Baharvand,et al.  Effect of poly-L-lysine coating on retinoic acid-loaded PLGA microspheres in the differentiation of carcinoma stem cells into neural cells. , 2010, The International journal of artificial organs.

[2]  Y. Leng,et al.  Biofabrication of a PLGA–TCP‐based porous bioactive bone substitute with sustained release of icaritin , 2015, Journal of tissue engineering and regenerative medicine.

[3]  Miqin Zhang,et al.  Preparation of porous hydroxyapatite scaffolds by combination of the gel-casting and polymer sponge methods. , 2003, Biomaterials.

[4]  F. Mallein-Gerin,et al.  VEGF and VEGF receptors are differentially expressed in chondrocytes. , 2007, Bone.

[5]  D. Alexander,et al.  Coating of ß-tricalcium phosphate scaffolds—a comparison between graphene oxide and poly-lactic-co-glycolic acid , 2015, Biomedical materials.

[6]  Xiaoyan Yuan,et al.  Controllable dual-release of dexamethasone and bovine serum albumin from PLGA/β-tricalcium phosphate composite scaffolds. , 2011, Journal of biomedical materials research. Part B, Applied biomaterials.

[7]  D. Cochran,et al.  Crestal bone changes around titanium implants. A histometric evaluation of unloaded non-submerged and submerged implants in the canine mandible. , 1997, Journal of periodontology.

[8]  H. Nowzari,et al.  Risk of prion disease transmission through bovine-derived bone substitutes: a systematic review. , 2013, Clinical implant dentistry and related research.

[9]  M. Longaker,et al.  Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. , 2002, Plastic and reconstructive surgery.

[10]  D. Mooney,et al.  Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  Pol Maria Rommens,et al.  The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. , 2008, Biomaterials.

[12]  Yunqing Kang,et al.  Enhanced mechanical performance and biological evaluation of a PLGA coated β-TCP composite scaffold for load-bearing applications. , 2011, European polymer journal.

[13]  D. Yu,et al.  Bone regeneration of critical calvarial defect in goat model by PLGA/TCP/rhBMP-2 scaffolds prepared by low-temperature rapid-prototyping technology. , 2008, International journal of oral and maxillofacial surgery.

[14]  A. Khojasteh,et al.  Bone regeneration with a combination of nanocrystalline hydroxyapatite silica gel, platelet-rich growth factor, and mesenchymal stem cells: a histologic study in rabbit calvaria. , 2013, Oral surgery, oral medicine, oral pathology and oral radiology.

[15]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[16]  Jacqueline Alblas,et al.  The role of endothelial progenitor cells in prevascularized bone tissue engineering: development of heterogeneous constructs. , 2010, Tissue engineering. Part A.

[17]  C. Susin,et al.  Periodontal wound healing/regeneration following the application of rhGDF-5 in a beta-TCP/PLGA carrier in critical-size supra-alveolar periodontal defects in dogs. , 2010, Journal of clinical periodontology.

[18]  L. Gibson.  The mechanical behaviour of cancellous bone. , 1985, Journal of biomechanics.

[19]  M. Rohrer,et al.  Clinical evaluation alveolar ridge preservation with a beta-tricalcium phosphate socket graft. , 2009, Compendium of continuing education in dentistry.

[20]  A. Khojasteh,et al.  Bone engineering in dog mandible: Coculturing mesenchymal stem cells with endothelial progenitor cells in a composite scaffold containing vascular endothelial growth factor. , 2017, Journal of biomedical materials research. Part B, Applied biomaterials.

[21]  D. Bezuidenhout,et al.  The dosage dependence of VEGF stimulation on scaffold neovascularisation. , 2008, Biomaterials.

[22]  A. Bandyopadhyay,et al.  Polycaprolactone coated porous tricalcium phosphate scaffolds for controlled release of protein for tissue engineering. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[23]  S. Madihally,et al.  Hybrid macroporous gelatin/bioactive-glass/nanosilver scaffolds with controlled degradation behavior and antimicrobial activity for bone tissue engineering. , 2014, Journal of biomedical nanotechnology.

[24]  M. Alini,et al.  Endothelial Progenitor Cell Fraction Contained in Bone Marrow-Derived Mesenchymal Stem Cell Populations Impairs Osteogenic Differentiation , 2015, BioMed research international.

[25]  David J Mooney,et al.  Effects of VEGF temporal and spatial presentation on angiogenesis. , 2010, Biomaterials.

[26]  Ming Liu,et al.  Coculture of peripheral blood-derived mesenchymal stem cells and endothelial progenitor cells on strontium-doped calcium polyphosphate scaffolds to generate vascularized engineered bone. , 2015, Tissue engineering. Part A.

[27]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[28]  Jian Li,et al.  Mechanical and Biological Properties of Hydroxyapatite/tricalcium Phosphate Scaffolds Coated with Poly(lactic-co-glycolic Acid) , 2007 .

[29]  Amy J Wagoner Johnson,et al.  A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. , 2011, Acta biomaterialia.

[30]  D. Camerino,et al.  Estimating the Impact of Workplace Bullying: Humanistic and Economic Burden among Workers with Chronic Medical Conditions , 2015, BioMed research international.

[31]  R. Reis,et al.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery. , 2013, Tissue engineering. Part B, Reviews.

[32]  K. Ogawa,et al.  Bone augmentation using a highly porous PLGA/β-TCP scaffold containing fibroblast growth factor-2. , 2015, Journal of periodontal research.

[33]  R. G. Richards,et al.  Direct Cell-Cell Contact between Mesenchymal Stem Cells and Endothelial Progenitor Cells Induces a Pericyte-Like Phenotype In Vitro , 2014, BioMed research international.

[34]  M. Alini,et al.  3D scaffolds co-seeded with human endothelial progenitor and mesenchymal stem cells: evidence of prevascularisation within 7 days. , 2013, European cells & materials.

[35]  M. Soleimani,et al.  Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[36]  M. Viana,et al.  Fabrication of porous substrates: a review of processes using pore forming agents in the biomaterial field. , 2008, Journal of pharmaceutical sciences.

[37]  Reza Masaeli,et al.  Applications of PLGA in Dentistry , 2015 .

[38]  Gordon C Jayson,et al.  Angiogenesis as a therapeutic target in cancer. , 2008, Clinical medicine.

[39]  S. Papapoulos,et al.  Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A. , 2002, Endocrinology.

[40]  B. von Rechenberg,et al.  Controlled release of tetracycline from biodegradable beta-tricalcium phosphate composites. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.